Latest Information Update: 09 Oct 2001
Price : $50 *
At a glance
- Originator Janssen L.P.
- Class Cardiotonics
- Mechanism of Action Phosphoric diester hydrolase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Acute heart failure
Most Recent Events
- 09 Oct 2001 No-Development-Reported for Acute heart failure in Belgium (Unknown route)